05 Compliance

The regulatory file for chymotrypsin

Technical document 05 · Reviewed 2026-11-19 · Chymotrypsin

On this page
  1. What the file contains
  2. European Union
  3. United States
  4. Contaminants and limits
  5. Claims and the label
  6. Documents in the file
  7. Checklist before the first order

Chymotrypsin is an enzyme preparation, so the regulatory file has three anchors: where the material comes from, what the specification measures, and where the finished product will be sold. Origin shapes the species and TSE documents, the specification shapes the activity method and contaminant panel, and the destination shapes the route and label. The buyer's regulatory team confirms the route; this page maps the frameworks and the documents.

In one line

A chymotrypsin file is only as good as its source record and its method, and the destination market decides which route and label apply.

What the file contains

A file that can be reviewed answers four practical things. It names the material and the specification revision; it carries the certificate for the lot on the dock; it shows the limits and label rules that the destination applies to the finished product; and it records what happens when the source, the carrier or the particle size changes. The certificate covers the lot, the technical data sheet covers the specification and the safety data sheet covers handling. None of them answers the route question.

For an enzyme like this, three statements carry more weight than the rest: the species and tissue of origin, the TSE position when the material is pancreas-derived, and the identity of the carrier. A lactose carrier brings a milk allergen with it, so the allergen statement should name the carrier and not only the enzyme. If the material is fermentation-derived, the production organism and its construction replace the TSE question, and the file needs a different set of documents.

European Union

In the EU, Regulation (EC) No 1332/2008 is the food-enzyme framework, and it requires a food enzyme to be on the Union list before it can be placed on the market, whether it acts as an ingredient or as a processing aid. The list is still being completed; EFSA has published safety evaluations for chymotrypsin preparations, including one produced by a genetically modified Bacillus licheniformis strain. The buyer's regulatory team checks the current list and confirms that the preparation and the use are covered, as of this review.

Alongside it, Regulation (EC) No 999/2001 sets the TSE rules for animal material. Pancreas is not classified as specified risk material, but the regulation still asks for the species, the tissue and the country of origin, and those belong in the file. Regulation (EU) No 1169/2011 then decides whether the enzyme appears on the label: a processing aid that leaves no technological function in the finished food need not be declared, whereas an enzyme that stays in a supplement as an ingredient must be. Supplement labelling also depends on the member state.

United States

The US route depends on what the ingredient is doing. A food enzyme usually rests on a GRAS basis, which can come from a listing in 21 CFR Part 184, from a GRAS notice reviewed under 21 CFR Part 170, or from a self-affirmed conclusion supported by the supplier's evidence. A dietary supplement needs the dietary-ingredient framework, and a new dietary ingredient question looks at the marketing history before 15 October 1994. The buyer's regulatory team decides which basis applies to the finished product.

The panel, the other ingredients and the claim are reviewed separately. An activity figure on a certificate is not a permission, and a permitted ingredient does not turn an activity figure into a claim.

Contaminants and limits

The catalog limits apply to the powder as released. The file also needs the calculation at the daily dose, since a result that looks comfortable per kilogram can be close to the limit in a capsule. The table lists the panel and what the finished-product file should show.

Catalog limits and the finished-product calculation
ParameterCatalog limitWhat the file should show
Lead (Pb)≤3 mg/kgThe lot figure, the method and the intake calculation
Arsenic (As)≤2 mg/kgThe lot figure and the destination limit
Cadmium (Cd)≤1 mg/kgThe lot figure and any category exception
Mercury (Hg)≤0.1 mg/kgThe lot figure and the method
MicrobiologyAPC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absentCounts, absence statements and the methods used
Loss on drying≤5.0%The measured value, because water lowers activity per gram

Claims and the label

No disease-related claim belongs on a chymotrypsin product, and enzyme activity is not a clinical effect. Any structure or function sentence is checked by the brand's reviewer against the market, the dosage form and the finished product; that check is independent of the certificate. A certificate describes a lot, not a label.

Two habits cause trouble. The first is to describe the enzyme by the protein it breaks down, which turns a technical property into a physiological claim. The second is to print “protease” on the panel when the specification names chymotrypsin, which loses the identity the rest of the file establishes. Use the enzyme name and the source, and leave the wording to the reviewer.

Great Britain and Northern Ireland follow separate routes. The GB file is checked against the GB register and GB labelling rules; Northern Ireland stays inside the EU framework. The buyer keeps the evidence for whichever route the destination requires.

Documents in the file

Documents to request with the first lot
DocumentWhat it establishesAsk for it when
SpecificationRevision, activity, method and limitsBefore accepting the quotation
COAResults for the lot that shipsWith every lot
Technical data sheetForm, solubility, storage and packagingDuring supplier qualification
Safety data sheetDust, sensitisation and safe handlingQualification and warehouse use
Source and TSE statementSpecies, tissue, country and TSE positionBefore the first shipment
Allergen and carrier statementCarrier identity and allergen riskBefore the label is designed
GMO and origin statementProduction organism and manufacturing siteAt qualification
Residual solvent statementSolvents used in purificationWhere the market requires it

Checklist before the first order

  • The specification identifies the enzyme, its source, CAS 9004-07-3 and the ATEE method.
  • Versioned copies of the COA, TDS and SDS are in the file.
  • Source, TSE position and carrier are all confirmed in writing.
  • The metals results have been recalculated for the daily dose.
  • A destination review covers both the label text and the claim.
  • Change control extends to source, carrier and particle size.

The catalog entry is on the chymotrypsin product page; the COA page explains the lot certificate, the identity page covers the analytical evidence, while the EU and US regulatory notes give the framework references. Release handling is described on the quality page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation